BioCentury | Aug 15, 2019
Clinical News

At last, a win for terlipressin -- and Mallinckrodt

...as patients alive at day 14 who demonstrated a reversal of HRS-1. Following FDA’s decision, Ikaria Inc....
...see "Mallinckrodt to Acquire Ikaria for $2.3B" ). While the deal was largely focused on Ikaria's...
BioCentury | May 23, 2019
Company News

With Merck veterans at the helm, Nektar launches subsidiary for pain compound

...of Alta Life Sciences and CMO at multiple biopharmas including Cara Therapeutics Inc. (NASDAQ:CARA) and Ikaria Inc....
BioCentury | Aug 22, 2016
Clinical News

Lucassin terlipressin: Phase III started

...develop and commercialize terlipressin through its 2015 acquisition of Ikaria Inc. (see BioCentury, May 25, 2015). Ikaria...
BioCentury | May 30, 2016
Finance

It takes a village

...fund, which closed at $65 million in the fall of 2002, included Ilypsa Inc. and Ikaria Inc....
...bought chronic kidney disease (CKD) company Ilypsa for $420 million in 2007. Respiratory failure company Ikaria...
BioCentury | Sep 14, 2015
Finance

Periodic piece

...About a decade after an Arch Venture-led syndicate formed Ikaria Inc. to develop elemental reducing agents for...
...Nelsen. "Pharma has ignored these things but they're very biologically relevant." Despite positive preclinical data, Ikaria...
...reverted to Fred Hutchinson and was spun back into Faraday. We're trying to recreate the Ikaria...
BioCentury | Jul 28, 2015
Company News

Management tracks

...hired Scott Charles as SVP of finance. Charles was treasurer and VP of finance at Ikaria Inc....
BioCentury | Jul 28, 2015
Clinical News

Bellerophon plummets on BCM data

...inquiries. Bellerophon raised $60 million in an IPO in February. It was spun out from Ikaria Inc....
BioCentury | Jul 21, 2015
Company News

Management tracks

...SVP of business development and corporate planning. Habib was VP of business development strategy at Ikaria Inc....
BioCentury | May 25, 2015
Company News

Ikaria, Mallinckrodt deal

...Mallinckrodt completed its acquisition of Ikaria for $2.3 billion from an investor group led by private...
...an investor group led by private equity firm Madison Dearborn Partners (see BioCentury, March 9). Ikaria Inc....
BioCentury | May 21, 2015
Company News

Management tracks

...Peter Fernandes as VP and chief regulatory officer. He was VP of regulatory affairs at Ikaria Inc....
Items per page:
1 - 10 of 101
BioCentury | Aug 15, 2019
Clinical News

At last, a win for terlipressin -- and Mallinckrodt

...as patients alive at day 14 who demonstrated a reversal of HRS-1. Following FDA’s decision, Ikaria Inc....
...see "Mallinckrodt to Acquire Ikaria for $2.3B" ). While the deal was largely focused on Ikaria's...
BioCentury | May 23, 2019
Company News

With Merck veterans at the helm, Nektar launches subsidiary for pain compound

...of Alta Life Sciences and CMO at multiple biopharmas including Cara Therapeutics Inc. (NASDAQ:CARA) and Ikaria Inc....
BioCentury | Aug 22, 2016
Clinical News

Lucassin terlipressin: Phase III started

...develop and commercialize terlipressin through its 2015 acquisition of Ikaria Inc. (see BioCentury, May 25, 2015). Ikaria...
BioCentury | May 30, 2016
Finance

It takes a village

...fund, which closed at $65 million in the fall of 2002, included Ilypsa Inc. and Ikaria Inc....
...bought chronic kidney disease (CKD) company Ilypsa for $420 million in 2007. Respiratory failure company Ikaria...
BioCentury | Sep 14, 2015
Finance

Periodic piece

...About a decade after an Arch Venture-led syndicate formed Ikaria Inc. to develop elemental reducing agents for...
...Nelsen. "Pharma has ignored these things but they're very biologically relevant." Despite positive preclinical data, Ikaria...
...reverted to Fred Hutchinson and was spun back into Faraday. We're trying to recreate the Ikaria...
BioCentury | Jul 28, 2015
Company News

Management tracks

...hired Scott Charles as SVP of finance. Charles was treasurer and VP of finance at Ikaria Inc....
BioCentury | Jul 28, 2015
Clinical News

Bellerophon plummets on BCM data

...inquiries. Bellerophon raised $60 million in an IPO in February. It was spun out from Ikaria Inc....
BioCentury | Jul 21, 2015
Company News

Management tracks

...SVP of business development and corporate planning. Habib was VP of business development strategy at Ikaria Inc....
BioCentury | May 25, 2015
Company News

Ikaria, Mallinckrodt deal

...Mallinckrodt completed its acquisition of Ikaria for $2.3 billion from an investor group led by private...
...an investor group led by private equity firm Madison Dearborn Partners (see BioCentury, March 9). Ikaria Inc....
BioCentury | May 21, 2015
Company News

Management tracks

...Peter Fernandes as VP and chief regulatory officer. He was VP of regulatory affairs at Ikaria Inc....
Items per page:
1 - 10 of 101